Search
Interviews with the world’s key opinion leaders in cancer

CategoryNews

Initital Gleason no guide in salvage therapy

The main message from Karim Fizazi MD PhD is that you should not let the lack of a threatening Gleason grade at initial diagnosis deter you from using abiraterone therapy much later on: there appears to be no relationship at all between initial...